| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |